In order to investigate the contribution of NFκB and RAGE in the observed effect of HG and CML on CD147 expression, cells were preincubated with either the NFκB inhibitory peptide (15 μg/mL) or RAGE antibody (20 μg/mL) for 2 h before the incubation with HG and CML. This evidence concerns the gene NFKB1 and chronic myelogenous leukemia, BCR-ABL1 positive.